维普期刊资源整合服务平台（V6.5）

55篇 您的检索式：作者名="ABRAMS TJ"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	SU11248 inhibits KIT and plateletderived growth factor receptor beta in preclinical models of human small cell lung cancer显示文摘	Abrams TJ Lee LB Murray LJ	2003	Mol Cancer Ther2003，2，5：	1
2	SU11248 inhibits KIT and platelet-derived growth factor receptor 13 in preclinical models of hu- man small cell lung cancer 显示文摘	Abrams TJ Lee LB Murray LJ	2003	Mol Cancer Ther2003，2，：	1
3	SUl1248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo 显示文摘	O'FARRELL AM ABRAMS TJ YUEN HA	2003	Blood2003，101，9：	1
4	SUl1248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer 显示文摘	Abrams TJ Lee LB Murray LJ	2003	Mol Cancer Ther2003，2，24：	1
5	SU11248 inhibits KIT and platelet-derived growth factor receptor β in preclinical models of human small cell lungcancer显示文摘	Abrams TJ Lee LB Murray LJ	2003	Molecular Cancer Therapeutics2003，2，2：	1
6	SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo显示文摘	O’Farrell AM Abrams TJ Yuen HA	2003	Blood2003，101，9：	1
7	SU11248 inhibits tumor growth and CSF-1R dependent osteolysis in an experimental breast cancer bone metastasis model显示文摘	Murray LJ Abrams TJ Long KR	2003	Clin Exp Metastasis2003，20，8：	1
8	Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence显示文摘	Keane DP Sims TJ Abrams P	1997	Br J Obstet Gynaecol1997，104，9：	1
9	SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model 显示文摘	Murray LJ Abrams TJ Long KR	2003	Clin Exp Metastasis2003，20，22：	1
10	SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo 显示文摘	O' Farrell AM Abrams TJ Yuen HA	2003	Blood2003，101，25：	1
11	Analysis of collagen status in premenopausal nulliparrous women with genuine stress incontinence显示文摘	Declan P Sims TJ Abrams P	1997	Br J Obstet Gynecol1997，104，：	1
12	Analysis of collagen status in premenopausal mulliparous women with genuine stress incontinence显示文摘	Declan P Sims TJ Abrams P	1997	Br J Obstet Gynecol1997，104，9：	1
13	SU11248 inhibits KIT and platelet - derived growth factor receptor 13 in preclinical models of human small cell lung cancer显示文摘	Abrams TJ Lee LB Murray LJ	2003	Molecular Cancer Therapeutics2003，2，2：	1
14	Analysis of collagen status in permenopausal mulliparous women with genuines terssin continence显示文摘	Declan P Sims TJ Abrams P	1997	Br J Obstet Gynecol1997，104，9：	1
15	SUl1248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer 显示文摘	Abrams TJ Lee LB Murray LJ	2003	Mol Cancer Ther2003，2，5：	1
16	How tumours escape mass de- struction显示文摘	STEWART TJ ABRAMS SI	2008	Oncogene2008，27，45：	1
17	Analysis of collagen status in premenopausal nuuiparors women with genuine stress incontinence显示文摘	Keane CP Sims TJ Abrams P	1997	Br J Obstet Gynocol1997，124，：	1
18	Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence 显示文摘	Keane DP Sims TJ Abrams P	1997	Br J Obstet Gynaecol1997，104，：	1
19	Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence 显示文摘	Keane DP Sims TJ Abrams P	1997	Br J Obstet Gynecol1997，104，：	1
20	SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo 显示文摘	O' Farrell AM Abrams TJ Yuen HA	2003	Blood2003，101，9：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示